Latest On MEI Pharma, Inc (MEIP):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-11-16 04:49 EST | Dividend | A dividend of $1.75 has been announced on Nov 6, 2023. It will be paid Dec 6, 2023 with an ex-dividend date of Nov 16, 2023. | Neutral |  |
| 2023-05-31 07:34 EST | News | MEI Pharma receives unsolicited acquisition proposal; up 10% | N/A | |
| 2023-05-11 22:11 EST | News | MEI Pharma Non-GAAP EPS of -$2.32 beats by $0.48, revenue of $5.89M beats by $5.43M | N/A | |
| 2023-04-15 03:18 EST | News | MEI Pharma falls on 1-for-20 reverse stock split | N/A | |
| 2023-02-23 17:09 EST | News | MEI Pharma and Infinity Pharma ink all-stock merger deal | N/A | |
| 2023-02-10 02:40 EST | News | MEI Pharma GAAP EPS of $0.08 beats by $0.29, revenue of $32.74M beats by $29.4M | N/A | |
| 2022-12-06 22:20 EST | News | MEI Pharma slumps on ending lead drug development ex-Japan, analysts downgrade stock | N/A | |
| 2022-12-06 04:24 EST | News | MEI Pharma slumps ~34% after ending development of its cancer treatment outside of Japan | N/A | |
| 2022-12-06 04:24 EST | News | MEI Pharma to reduce workforce by about 30%, refocus development on earlier assets | N/A | |
| 2022-11-18 17:26 EST | News | Mei Pharma releases top-line, mid-stage data on zandelisib for Non-Hodgkin’s Lymphoma | N/A | |
| 2022-11-15 04:51 EST | News | MEI Pharma GAAP EPS of -$0.12 beats by $0.04, revenue of $8.73M beats by $4.31M | N/A | |
| 2022-09-17 06:30 EST | News | MEI Pharma (MEIP) Investor Presentation - Slideshow | N/A | |
| 2022-09-10 00:49 EST | News | MEI Pharma stock trades higher as FY22 revenue grows 17% | N/A | |
| 2022-09-09 07:31 EST | News | MEI Pharma GAAP EPS of -$0.50 misses by $0.03, revenue of $40.7M misses by $1.09M | N/A | |
| 2022-09-09 07:31 EST | News | MEI Pharma, Inc. (MEIP) Q4 2022 Earnings Call Transcript | N/A | |
| 2022-05-24 00:36 EST | News | MEI Pharma GAAP EPS of -$0.07 beats by $0.11, revenue of $9.7M beats by $6.26M | N/A | |
| 2022-05-16 15:12 EST | News | MEI Pharma to restate financials after errors in revenue recognition | N/A | |
| 2022-03-26 04:56 EST | News | MEI Pharma falls on setback to U.S. marketing application for lymphoma therapy | N/A | |
| 2022-03-26 04:56 EST | News | MEI Pharma posts a historic drop as setback to cancer drug draws downgrades | N/A | |
| 2022-02-11 06:05 EST | News | MEI Pharma GAAP EPS of -$0.09, revenue of $18.22M | N/A | |
| 2022-02-01 11:39 EST | News | MEI Pharma: Another PI3K Delta Progressing To The FDA | N/A | |
| 2022-01-03 23:30 EST | News | MEI Pharma announces inducement grants of 155K shares to seven new employees | N/A | |
| 2021-12-02 01:24 EST | News | MEI Pharma raises $45.5M capital via stock offering | N/A | |
| 2021-12-01 04:59 EST | News | MEI Pharma launches offering of 17.5M common shares | N/A | |
| 2021-11-30 07:50 EST | News | MEI Pharma jumps 10% on promising zandelisib data in follicular lymphoma | N/A | |
| 2021-11-11 09:20 EST | News | MEI Pharma EPS misses by $0.01, beats on revenue | N/A | |
| 2021-11-10 11:47 EST | News | MEI Pharma and Kyowa Kirin get FDA orphan drug designation for zandelisib | N/A | |
| 2021-09-22 00:17 EST | News | MEI Pharma (MEIP) Presents At 23rd Annual Global Investment Virtual Conference - Slideshow | N/A | |
| 2021-09-11 00:38 EST | News | MEI Pharma (MEIP) presents at 2021 Wells Fargo Healthcare Virtual Conference | N/A | |
| 2021-09-03 18:58 EST | News | MEI Pharma, Inc. (MEIP) CEO Dan Gold on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2021-09-02 22:47 EST | News | MEI Pharma EPS misses by $0.11, beats on revenue | N/A | |
| 2021-09-02 02:56 EST | News | MEI Pharma FY 2021 Earnings Preview | N/A | |
| 2021-08-17 17:02 EST | News | Dosing underway in MEI Pharma, Kyowa Kirin's zandelisib combo study in B-cell lymphoma | N/A | |
| 2021-08-06 06:42 EST | News | MEI Pharma CFO Brian Drazba to retire | N/A | |
| 2021-05-07 11:44 EST | News | MEI Pharma EPS misses by $0.12, misses on revenue | N/A | |
| 2021-04-30 14:49 EST | News | MEI Pharma promotes Richard Ghalie to chief medical officer | N/A | |
| 2021-04-26 23:53 EST | News | MEI Pharma shares rise 4% as Wells Fargo says voruciclib undervalued | N/A | |
| 2021-04-16 16:18 EST | News | MEI Pharma (MEIP) Presents At AACR Virtual Meeting 2021 - Slideshow | N/A | |
| 2021-02-06 03:59 EST | Financials | Company financials have been released. | Neutral | |
| 2021-02-04 17:44 EST | News | MEI Pharma EPS beats by $0.01, beats on revenue | N/A | |
| 2021-01-06 16:09 EST | Financials | Company financials have been released. | Neutral | |
| 2021-01-05 12:16 EST | Analyst Rating | The Analyst Target Price has increased from $9.45 to $9.6. | Buy | |
| 2021-01-05 02:52 EST | News | MEI Pharma expands early-stage zandelisib trial in specific blood cancer cohorts | N/A | |
| 2020-12-27 01:59 EST | News | MEI Pharma: Give It Another Chance | N/A | |
| 2020-11-26 20:47 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-14 04:40 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-11 12:25 EST | Earnings Estimate | An EPS average of -$0.08 is estimated for the quarter ending on March 31, 2021. | Sell | |
| 2020-11-10 19:22 EST | News | MEI Pharma EPS misses by $0.06, beats on revenue | N/A | |
| 2020-11-07 16:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-13 09:18 EST | Analyst Rating | The Analyst Target Price has increased from $9.39 to $9.45. | Buy | |
About MEI Pharma, Inc (MEIP):
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase II clinical trial for the treatment of patients with relapsed/refractory follicular lymphoma, as well as in Phase Ib multi-arm trial to treat B-cell malignancies; and Voruciclib, an oral cyclin-dependent kinase inhibitor, which is in Phase Ib clinical trial for acute myeloid leukemia and B-cell malignancies. It also develops ME-344, a mitochondrial inhibitor targeting the oxidative phosphorylation complex that is in Phase I clinical trial for the treatment of human epidermal growth factor receptor 2 negative breast cancer; and Pracinostat, an oral available histone deacetylase inhibitor, which is in Phase II clinical trial to treat patients with myelodysplastic syndrome. The company has a license, development, and commercialization agreement with Kyowa Kirin Company; a clinical collaboration with BeiGene, Ltd.; a license, development, manufacturing, and commercialization agreement with Helsinn Healthcare SA; and license agreements with Presage Biosciences, Inc. and CyDex Pharmaceuticals, Inc. The company was formerly known as Marshall Edwards, Inc. and changed its name to MEI Pharma, Inc. in July 2012. MEI Pharma, Inc. was founded in 2000 and is headquartered in San Diego, California.
General
- Name MEI Pharma, Inc
- Symbol MEIP
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 51
- Last Split Factor1:6
- Last Split Date2012-12-19
- Fiscal Year EndJune
- IPO Date2003-12-19
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.meipharma.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 9.97
- Price/Book (Most Recent Quarter) 5.5
- Enterprise Value Revenue 5.85
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$0.49
- Next Year EPS Estimate -$0.44
- Next Quarter EPS Estimate -$0.12
- Profit Margin -91%
- Operating Margin -87%
- Return on Assets -14%
- Return on Equity -48%
- Revenue 39.75 million
- Earnings Per Share -$0.75
- Revenue Per Share $0.36
- Gross Profit 26.24 million
- Quarterly Earnings Growth 809.4%
View More
Highlights
- Market Capitalization 407.35 million
- EBITDA -46165000
- PE Ratio 1.02
- PEG Ratio 20.6
- Analyst Target Price $9.6
- Book Value Per Share $0.65
View More
Share Statistics
- Shares Outstanding 112.53 million
- Shares Float 90.68 million
- % Held by Insiders 285%
- % Held by Institutions 69.88%
- Shares Short 9.74 million
- Shares Short Prior Month 8.49 million
- Short Ratio 6.87
- Short % of Float 9%
- Short % of Shares Outstanding 9%
View More
Technicals
- Beta 1.52
- 52 Week High $4.54
- 52 Week Low $0.96
- 50 Day Moving Average 3.76
- 200 Day Moving Average 3.13
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
MEI Pharma, Inc (MEIP) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
MEI Pharma, Inc (MEIP) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-04 | $9.17 million | -$0.10 | -$0.17 | 42.16% |
| 2020-09-30 | 2020-11-10 | $N/A | -$0.02 | -$0.08 | 75.61% |
| 2020-06-30 | 2020-09-09 | $25.5 million | -$0.17 | $0.13 | -232.19% |
| 2020-03-31 | 2020-05-07 | $N/A | -$0.04 | -$0.14 | 70.37% |
| 2019-12-31 | 2020-02-06 | $1.01 million | -$0.26 | -$0.17 | -52.94% |
| 2019-09-30 | 2019-11-07 | $1.16 million | -$0.04 | -$0.17 | 76.47% |
| 2019-06-30 | 2019-08-28 | $1.13 million | $0.04 | -$0.16 | 124.49% |
| 2019-03-31 | 2019-05-09 | $1.25 million | -$0.24 | -$0.15 | -56.56% |
| 2018-12-31 | 2019-02-07 | $2.05 million | $0.17 | -$0.12 | 241.67% |
| 2018-09-30 | 2018-11-08 | $488000 | -$0.21 | -$0.12 | -81.03% |
| 2018-06-30 | 2018-08-30 | $548000 | -$0.36 | -$0.22 | -65.52% |
| 2018-03-31 | 2018-05-09 | $433000 | -$0.16 | -$0.24 | 34.02% |
| 2017-12-31 | 2018-02-08 | $358000 | -$0.16 | -$0.26 | 37.67% |
| 2017-09-30 | 2017-11-08 | $283000 | -$0.24 | -$0.29 | 16.29% |
| 2017-06-30 | 2017-09-05 | $449000 | -$0.12 | -$0.16 | 25% |
| 2017-03-31 | 2017-05-04 | $4.51 million | -$0.02 | -$0.04 | 42.86% |
| 2016-12-31 | 2017-02-08 | $17.2 million | $0.32 | -$0.29 | 212.28% |
| 2016-09-30 | 2016-11-09 | $1.1 million | -$0.12 | -$0.15 | 20% |
| 2016-06-30 | 2016-09-06 | $N/A | -$0.17 | -$0.16 | -9.68% |
| 2016-03-31 | 2016-05-05 | $N/A | -$0.16 | -$0.15 | -10.34% |
| 2015-12-31 | 2016-02-05 | $N/A | -$0.15 | -$0.14 | -7.14% |
| 2015-09-30 | 2015-11-06 | $N/A | -$0.13 | -$0.17 | 23.53% |
| 2015-06-30 | 2015-09-02 | $N/A | -$0.13 | -$0.21 | 38.1% |
| 2015-03-31 | 2015-05-07 | $N/A | -$0.27 | -$0.27 | 0% |
| 2014-12-31 | 2015-02-06 | $N/A | -$0.39 | -$0.39 | 0% |
| 2014-09-30 | 2014-11-06 | $N/A | -$0.42 | -$0.38 | -10.53% |
| 2014-06-30 | 2014-09-09 | $N/A | -$0.40 | -$0.35 | -14.29% |
| 2014-03-31 | 2014-05-08 | $N/A | -$0.34 | -$0.30 | -13.33% |
| 2013-12-31 | 2014-02-11 | $N/A | -$0.32 | -$0.24 | -33.33% |
| 2013-09-30 | 2013-11-08 | $N/A | -$0.29 | -$0.20 | -45% |
| 2013-06-30 | 2013-09-18 | $N/A | -$0.19 | -$0.14 | -35.71% |
| 2013-03-31 | 2013-05-09 | $N/A | -$0.18 | -$0.20 | 10% |
| 2012-12-31 | 2013-02-12 | $N/A | -$0.50 | -$0.23 | -117.39% |
| 2012-09-30 | 2012-11-13 | $N/A | -$0.72 | -$0.84 | 14.29% |
| 2012-06-30 | 2012-09-18 | $N/A | -$0.72 | -$0.90 | 20% |
| 2012-03-31 | 2012-05-15 | $N/A | -$0.90 | -$0.78 | -15.38% |
| 2011-12-31 | 2012-02-10 | $N/A | -$0.78 | ||
| 2011-09-30 | 2011-11-30 | $N/A | -$1.01 | ||
| 2011-06-30 | 2011-08-26 | $N/A | -$1.14 | ||
| 2011-03-31 | 2011-05-13 | $N/A | -$1.06 | ||
| 2010-12-31 | 2011-02-11 | $N/A | -$1.69 | ||
| 2010-09-30 | 2010-12-01 | $N/A | -$1.44 | ||
| 2010-06-30 | 2010-08-27 | $N/A | -$1.50 | ||
| 2010-03-31 | 2010-05-14 | $N/A | -$1.81 | ||
| 2009-12-31 | 2010-02-12 | $N/A | -$1.17 | ||
| 2009-09-30 | 2009-12-02 | $N/A | -$1.97 | ||
| 2009-06-30 | 2009-08-28 | $N/A | -$4.45 | ||
| 2009-03-31 | 2009-05-15 | $N/A | -$1.56 | ||
| 2008-12-31 | 2009-02-13 | $N/A | -$1.31 | ||
| 2008-09-30 | 2008-12-03 | $N/A | -$1.88 | ||
| 2008-06-30 | 2008-09-15 | $N/A | -$3.00 | -$2.40 | -25% |
| 2008-03-31 | 2008-05-07 | $N/A | -$3.00 | -$3.60 | 16.67% |
| 2007-12-31 | 2008-02-08 | $N/A | -$1.80 | -$3.60 | 50% |
| 2007-09-30 | 2007-11-07 | $N/A | -$3.00 | -$1.80 | -66.67% |
| 2007-06-30 | 2007-09-27 | $N/A | -$1.80 | -$1.80 | 0% |
| 2007-03-31 | 2007-05-08 | $N/A | -$1.80 | -$4.80 | 62.5% |
| 2006-12-31 | 2007-02-08 | $N/A | -$1.80 | -$1.80 | 0% |
| 2006-09-30 | 2006-11-08 | $N/A | -$7.80 | -$1.80 | -333.33% |
| 2006-06-30 | 2006-09-01 | $N/A | -$0.60 | -$3.60 | 83.33% |
| 2006-03-31 | 2006-05-09 | $N/A | -$3.60 | -$3.00 | -20% |
| 2005-12-31 | 2006-02-10 | $N/A | -$1.80 | -$2.40 | 25% |
| 2005-09-30 | 2005-11-14 | $N/A | -$1.80 | -$2.40 | 25% |
| 2005-06-30 | 2005-09-14 | $N/A | -$2.40 | -$2.40 | 0% |
| 2005-03-31 | 2005-05-13 | $N/A | -$1.80 | -$2.40 | 25% |
| 2004-12-31 | 2005-02-11 | $N/A | -$1.20 | -$1.20 | 0% |
| 2004-09-30 | 2004-11-15 | $N/A | -$1.20 | -$1.80 | 33.33% |
| 2004-06-30 | 2004-09-10 | $N/A | -$1.20 | -$1.80 | 33.33% |
| 2004-03-31 | 2004-05-14 | $N/A | -$1.80 | -$1.20 | -50% |
| 2003-12-31 | 2003-12-31 | $N/A | -$5.27 |
MEI Pharma, Inc (MEIP) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
MEI Pharma, Inc (MEIP) Chart:
MEI Pharma, Inc (MEIP) News:
Below you will find a list of latest news for MEI Pharma, Inc (MEIP) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
MEI Pharma, Inc (MEIP) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2024-05-17 | 1 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-05-17 | 2 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-05-17 | 3 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-05-17 | 4 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 6 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 7 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 1 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 2 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 3 | 0.35 | PUT | 0 | 41 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 4 | 1.66 | PUT | 0 | 10 | 0 | TRUE | 0 | 0 |
| 2024-05-17 | 5 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-05-17 | 6 | 0 | PUT | 0 | 0 | 407.61 | TRUE | 0 | 0 |
| 2024-05-17 | 7 | 0 | PUT | 0 | 0 | 252.82 | TRUE | 0 | 0 |
| 2024-06-21 | 0.25 | 2.63 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-06-21 | 1 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-06-21 | 1.25 | 0 | CALL | 0 | 0 | 447.06 | TRUE | 0 | 0 |
| 2024-06-21 | 2 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-06-21 | 2.25 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-06-21 | 3 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-06-21 | 3.25 | 0.75 | CALL | 0 | 148 | 441.16 | FALSE | 0 | 0 |
| 2024-06-21 | 4 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 4.25 | 0.5 | CALL | 0 | 113 | 595.78 | FALSE | 0 | 0 |
| 2024-06-21 | 5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 5.25 | 0.31 | CALL | 0 | 55 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 6 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 6.25 | 0.2 | CALL | 0 | 190 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 7 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 7.25 | 0.25 | CALL | 0 | 405 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 8 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 8.25 | 0.1 | CALL | 0 | 7 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 9 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 9.25 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 10 | 0 | CALL | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 10.25 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 11 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 11.25 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 12 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 13 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 0.25 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 1 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 1.25 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 2 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 2.25 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 3 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 3.25 | 0.7 | PUT | 0 | 122 | 108.89 | TRUE | 0 | 0 |
| 2024-06-21 | 4 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-06-21 | 4.25 | 1.55 | PUT | 0 | 316 | 157.05 | TRUE | 0 | 0 |
| 2024-06-21 | 5 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-06-21 | 5.25 | 2.3 | PUT | 0 | 2 | 247.35 | TRUE | 0 | 0 |
| 2024-06-21 | 6 | 0.6 | PUT | 0 | 19 | 0 | TRUE | 0 | 0 |
| 2024-06-21 | 6.25 | 2 | PUT | 0 | 1 | 255.22 | TRUE | 0 | 0 |
| 2024-06-21 | 7 | 1.65 | PUT | 1 | 1 | 0 | TRUE | 0 | 0 |
| 2024-06-21 | 7.25 | 2 | PUT | 0 | 0 | 278.15 | TRUE | 0 | 0 |
| 2024-06-21 | 8 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-06-21 | 8.25 | 0 | PUT | 0 | 0 | 297.27 | TRUE | 0 | 0 |
| 2024-06-21 | 9 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-06-21 | 9.25 | 0 | PUT | 0 | 0 | 243.79 | TRUE | 0 | 0 |
| 2024-06-21 | 10 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-06-21 | 10.25 | 0 | PUT | 0 | 2 | 327.96 | TRUE | 0 | 0 |
| 2024-06-21 | 11 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-06-21 | 11.25 | 0 | PUT | 0 | 0 | 435.01 | TRUE | 0 | 0 |
| 2024-06-21 | 12 | 6.1 | PUT | 2 | 2 | 0 | TRUE | 0 | 0 |
| 2024-06-21 | 13 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-09-20 | 1 | 2.53 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-09-20 | 2 | 2.5 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-09-20 | 3 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-09-20 | 4 | 1.2 | CALL | 0 | 3 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 5 | 0.7 | CALL | 0 | 11 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 6 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 7 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 8 | 0.35 | CALL | 0 | 3 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 1 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 2 | 0.2 | PUT | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 3 | 0.55 | PUT | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 4 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-09-20 | 5 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-09-20 | 6 | 0 | PUT | 0 | 0 | 162.9 | TRUE | 0 | 0 |
| 2024-09-20 | 7 | 0 | PUT | 0 | 0 | 233.59 | TRUE | 0 | 0 |
| 2024-09-20 | 8 | 0 | PUT | 0 | 0 | 188.78 | TRUE | 0 | 0 |
| 2024-12-20 | 1 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-12-20 | 2 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-12-20 | 3 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-12-20 | 4 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 6 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 1 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 2 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 3 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 4 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-12-20 | 5 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-12-20 | 6 | 0 | PUT | 0 | 0 | 56.33 | TRUE | 0 | 0 |
Latest MEIP Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:55 PM EST | 100 | $0.5177 |
| Jun 13, 2022 7:55 PM EST | 49 | $0.5179 |
| Jun 13, 2022 7:55 PM EST | 49 | $0.5177 |
| Jun 13, 2022 7:55 PM EST | 100 | $0.5179 |
| Jun 13, 2022 7:56 PM EST | 100 | $0.5201 |
MEI Pharma, Inc (MEIP) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-07-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1262104/000119312520185881/0001193125-20-185881-index.htm |
| 2018-06-13 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1262104/000000000018018238/0000000000-18-018238-index.htm |
| 2020-05-14 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1262104/000000000020004278/0000000000-20-004278-index.htm |
| 2018-06-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000089924318018105/0000899243-18-018105-index.htm |
| 2018-06-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000089924318018106/0000899243-18-018106-index.htm |
| 2018-06-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000089924318018107/0000899243-18-018107-index.htm |
| 2018-06-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000089924318018110/0000899243-18-018110-index.htm |
| 2020-04-14 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000089924320010721/0000899243-20-010721-index.htm |
| 2020-04-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000089924320010723/0000899243-20-010723-index.htm |
| 2020-07-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000089924320018597/0000899243-20-018597-index.htm |
| 2020-07-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000089924320018601/0000899243-20-018601-index.htm |
| 2020-07-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000089924320018606/0000899243-20-018606-index.htm |
| 2020-07-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000089924320018610/0000899243-20-018610-index.htm |
| 2020-07-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000089924320018611/0000899243-20-018611-index.htm |
| 2020-07-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000089924320018612/0000899243-20-018612-index.htm |
| 2020-07-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000089924320018613/0000899243-20-018613-index.htm |
| 2020-07-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000089924320018614/0000899243-20-018614-index.htm |
| 2020-07-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000089924320018615/0000899243-20-018615-index.htm |
| 2020-07-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000089924320018616/0000899243-20-018616-index.htm |
| 2020-07-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000089924320018617/0000899243-20-018617-index.htm |
| 2020-07-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000089924320018618/0000899243-20-018618-index.htm |
| 2018-05-25 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1262104/000091957418003946/0000919574-18-003946-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1262104/000091957419001802/0000919574-19-001802-index.htm |
| 2018-05-29 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1262104/000092189518001843/0000921895-18-001843-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1262104/000092189519000455/0000921895-19-000455-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1262104/000092189520000520/0000921895-20-000520-index.htm |
| 2018-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1262104/000103738918000044/0001037389-18-000044-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1262104/000103738919000119/0001037389-19-000119-index.htm |
| 2018-05-23 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1262104/000107261318000354/0001072613-18-000354-index.htm |
| 2019-12-30 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1262104/000107261319000317/0001072613-19-000317-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1262104/000112329220000249/0001123292-20-000249-index.htm |
| 2017-12-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1262104/000119312517358880/0001193125-17-358880-index.htm |
| 2018-02-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1262104/000119312518035521/0001193125-18-035521-index.htm |
| 2018-02-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1262104/000119312518058267/0001193125-18-058267-index.htm |
| 2018-05-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1262104/000119312518156845/0001193125-18-156845-index.htm |
| 2018-05-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1262104/000119312518165462/0001193125-18-165462-index.htm |
| 2018-06-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1262104/000119312518182566/0001193125-18-182566-index.htm |
| 2018-06-06 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1262104/000119312518185737/0001193125-18-185737-index.htm |
| 2018-06-14 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1262104/000119312518192758/0001193125-18-192758-index.htm |
| 2018-06-18 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1262104/000119312518195683/0001193125-18-195683-index.htm |
| 2018-07-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1262104/000119312518218802/0001193125-18-218802-index.htm |
| 2018-08-30 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1262104/000119312518263586/0001193125-18-263586-index.htm |
| 2018-09-05 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1262104/000119312518267295/0001193125-18-267295-index.htm |
| 2018-09-14 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1262104/000119312518274146/0001193125-18-274146-index.htm |
| 2018-10-11 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1262104/000119312518297655/0001193125-18-297655-index.htm |
| 2018-10-11 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1262104/000119312518297661/0001193125-18-297661-index.htm |
| 2018-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1262104/000119312518317826/0001193125-18-317826-index.htm |
| 2018-11-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1262104/000119312518322588/0001193125-18-322588-index.htm |
| 2018-11-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1262104/000119312518339956/0001193125-18-339956-index.htm |
| 2018-12-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1262104/000119312518341242/0001193125-18-341242-index.htm |
| 2019-02-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1262104/000119312519030835/0001193125-19-030835-index.htm |
| 2019-02-07 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1262104/000119312519030863/0001193125-19-030863-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1262104/000119312519041041/0001193125-19-041041-index.htm |
| 2019-05-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1262104/000119312519142945/0001193125-19-142945-index.htm |
| 2019-06-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1262104/000119312519164088/0001193125-19-164088-index.htm |
| 2019-07-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1262104/000119312519189160/0001193125-19-189160-index.htm |
| 2019-08-28 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1262104/000119312519232454/0001193125-19-232454-index.htm |
| 2019-09-25 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1262104/000119312519254809/0001193125-19-254809-index.htm |
| 2019-10-23 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1262104/000119312519271911/0001193125-19-271911-index.htm |
| 2019-11-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1262104/000119312519287262/0001193125-19-287262-index.htm |
| 2019-12-06 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1262104/000119312519308275/0001193125-19-308275-index.htm |
| 2019-12-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1262104/000119312519308280/0001193125-19-308280-index.htm |
| 2019-12-16 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1262104/000119312519315266/0001193125-19-315266-index.htm |
| 2019-12-18 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1262104/000119312519316543/0001193125-19-316543-index.htm |
| 2019-12-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1262104/000119312519316554/0001193125-19-316554-index.htm |
| 2020-02-05 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1262104/000119312520025221/0001193125-20-025221-index.htm |
| 2020-02-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1262104/000119312520026751/0001193125-20-026751-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1262104/000119312520038284/0001193125-20-038284-index.htm |
| 2020-03-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1262104/000119312520080639/0001193125-20-080639-index.htm |
| 2020-04-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1262104/000119312520105808/0001193125-20-105808-index.htm |
| 2020-04-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1262104/000119312520106585/0001193125-20-106585-index.htm |
| 2020-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1262104/000119312520135561/0001193125-20-135561-index.htm |
| 2020-05-07 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1262104/000119312520135593/0001193125-20-135593-index.htm |
| 2020-05-14 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1262104/000119312520142862/0001193125-20-142862-index.htm |
| 2020-06-12 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1262104/000119312520167242/0001193125-20-167242-index.htm |
| 2020-07-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1262104/000119312520185881/0001193125-20-185881-index.htm |
| 2020-09-09 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1262104/000119312520242169/0001193125-20-242169-index.htm |
| 2020-10-27 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1262104/000119312520278378/0001193125-20-278378-index.htm |
| 2018-02-26 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000120919118013266/0001209191-18-013266-index.htm |
| 2018-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000120919118013268/0001209191-18-013268-index.htm |
| 2018-03-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000120919118022186/0001209191-18-022186-index.htm |
| 2018-07-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000120919118042663/0001209191-18-042663-index.htm |
| 2018-07-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000120919118042665/0001209191-18-042665-index.htm |
| 2018-07-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000120919118042667/0001209191-18-042667-index.htm |
| 2018-07-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000120919118042670/0001209191-18-042670-index.htm |
| 2018-07-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000120919118042673/0001209191-18-042673-index.htm |
| 2018-07-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000120919118042676/0001209191-18-042676-index.htm |
| 2018-07-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000120919118042678/0001209191-18-042678-index.htm |
| 2018-07-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000120919118042681/0001209191-18-042681-index.htm |
| 2018-07-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000120919118042683/0001209191-18-042683-index.htm |
| 2018-07-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000120919118042686/0001209191-18-042686-index.htm |
| 2018-07-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000120919118042688/0001209191-18-042688-index.htm |
| 2018-08-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000120919118045895/0001209191-18-045895-index.htm |
| 2018-08-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000120919118045897/0001209191-18-045897-index.htm |
| 2018-08-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000120919118045899/0001209191-18-045899-index.htm |
| 2018-09-06 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000120919118049972/0001209191-18-049972-index.htm |
| 2019-07-03 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000120919119040973/0001209191-19-040973-index.htm |
| 2019-07-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000120919119040974/0001209191-19-040974-index.htm |
| 2019-07-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000120919119040975/0001209191-19-040975-index.htm |
| 2019-07-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000120919119040976/0001209191-19-040976-index.htm |
| 2019-07-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000120919119040977/0001209191-19-040977-index.htm |
| 2019-07-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000120919119040979/0001209191-19-040979-index.htm |
| 2019-07-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000120919119040980/0001209191-19-040980-index.htm |
| 2019-07-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000120919119040981/0001209191-19-040981-index.htm |
| 2019-07-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000120919119040983/0001209191-19-040983-index.htm |
| 2019-07-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000120919119040984/0001209191-19-040984-index.htm |
| 2019-07-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000120919119040985/0001209191-19-040985-index.htm |
| 2019-07-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000120919119040987/0001209191-19-040987-index.htm |
| 2019-07-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000120919119040989/0001209191-19-040989-index.htm |
| 2019-09-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000120919119048913/0001209191-19-048913-index.htm |
| 2019-10-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000120919119051197/0001209191-19-051197-index.htm |
| 2019-12-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000120919119061469/0001209191-19-061469-index.htm |
| 2019-12-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000120919119061471/0001209191-19-061471-index.htm |
| 2019-12-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000120919119061473/0001209191-19-061473-index.htm |
| 2019-12-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000120919119061475/0001209191-19-061475-index.htm |
| 2020-07-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1262104/000120919120043719/0001209191-20-043719-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1262104/000121390020003605/0001213900-20-003605-index.htm |
| 2018-05-30 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1262104/000126210418000002/0001262104-18-000002-index.htm |
| 2018-05-21 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1262104/000161577418004152/0001615774-18-004152-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1262104/000161577419002511/0001615774-19-002511-index.htm |
| 2018-06-18 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1262104/999999999518001527/9999999995-18-001527-index.htm |
| 2020-05-18 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1262104/999999999520001189/9999999995-20-001189-index.htm |
| 2017-12-07 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1262104/999999999717010404/9999999997-17-010404-index.htm |
| 2019-02-22 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1262104/999999999719000562/9999999997-19-000562-index.htm |
MEI Pharma, Inc (MEIP) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of MEI Pharma, Inc (MEIP). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 285%Institutional Ownership: 6988%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2019-12-19 | Thomas C Reynolds | Director | Buy | 10,000.00 | 1.60 | 16,000.00 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/1262104/000120919119061475/0001209191-19-061475-index.htm |
| 2019-09-06 | Christine Anna White | Director | Buy | 15,000.00 | 1.74 | 26,074.50 | 15,000.00 | https://www.sec.gov/Archives/edgar/data/1262104/000120919119048913/0001209191-19-048913-index.htm |
| 2018-08-07 | David M Urso | Chief Operating Officer & GC | Sell | 9,500.00 | 3.58 | 34,044.20 | 24,106.00 | https://www.sec.gov/Archives/edgar/data/1262104/000120919118045899/0001209191-18-045899-index.htm |
| 2019-09-27 | DANIEL P PHD GOLD | Chief Executive Officer | Buy | 20,000.00 | 1.57 | 31,400.00 | 342,882.00 | https://www.sec.gov/Archives/edgar/data/1262104/000120919119051197/0001209191-19-051197-index.htm |
| 2019-12-19 | DANIEL P PHD GOLD | Chief Executive Officer | Buy | 18,750.00 | 1.60 | 30,000.00 | 361,632.00 | https://www.sec.gov/Archives/edgar/data/1262104/000120919119061469/0001209191-19-061469-index.htm |
| 2019-12-19 | Brian G. Drazba | Chief Financial Officer | Buy | 12,500.00 | 1.60 | 20,000.00 | 37,500.00 | https://www.sec.gov/Archives/edgar/data/1262104/000120919119061471/0001209191-19-061471-index.htm |
| 2020-07-02 | DANIEL P PHD GOLD | Chief Executive Officer | Buy | 80,000.00 | 441,632.00 | https://www.sec.gov/Archives/edgar/data/1262104/000089924320018601/0000899243-20-018601-index.htm | ||
| 2020-07-23 | DANIEL P PHD GOLD | Chief Executive Officer | Buy | 12,000.00 | 1.57 | 18,840.00 | 453,632.00 | https://www.sec.gov/Archives/edgar/data/1262104/000120919120043719/0001209191-20-043719-index.htm |
| 2019-12-19 | FREDERICK W DRISCOLL | Director | Buy | 62,500.00 | 1.60 | 100,000.00 | 62,500.00 | https://www.sec.gov/Archives/edgar/data/1262104/000120919119061473/0001209191-19-061473-index.htm |
| 2020-07-02 | David M Urso | Chief Operating Officer & GC | Buy | 50,000.00 | 74,106.00 | https://www.sec.gov/Archives/edgar/data/1262104/000089924320018614/0000899243-20-018614-index.htm |